It’s time to buy these 2 fallen ASX shares again: expert

One professional has named a pair of beaten-down stocks he that thinks is ready for a massive rebound.

| More on:
two smiling people, a man and a woman, raise a hand in a wave as they are tethered to each other while they skydive against a clear sky with a covering of clouds below before their parachute opens.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you think back to 2019, life was much simpler.

It was only three years ago, but no one outside of the medical profession had heard of the abbreviation COVID and inflation was non-existent. 

And if you look over investment articles such as this published back in 2019, there are some names often repeated.

But many of those former darlings have since endured a brutal period after the pandemic arrived, and have not really recovered since.

One expert, though, reckons it’s time to revisit two of those fallen stars:

Forget China, there is growth elsewhere

Investors in Kiwi company A2 Milk Company Ltd (ASX: A2M) have long been waiting for a turnaround.

After gaining a stunning 3,400% in the first five years after its 2015 listing, the shares have lost a sorry 77% since July 2020.

“This infant formula company has been facing supply chain issues and margin pressure from increasing competition, resulting in a major valuation decline in recent years,” Catapult Wealth financial adviser Tim Haselum told The Bull.

But he reckons it’s now time to buy the dairy producer.

“Even without strong growth in China, A2 Milk is expanding in New Zealand and the US,” said Haselum.

“Also, new markets in Malaysia, Singapore and Vietnam could lead to a recovery in 2023 and beyond.”

It could also have some unexpected tricks up its sleeve.

“With a strong net cash position, A2 Milk has plenty of firepower for mergers and acquisitions.”

The wider finance community is torn on the stock. According to CMC Markets, four of 15 analysts rate it as a buy while three are advising clients to sell, with the rest neutral.

50% profit growth? Yes, please

Technology shares have suffered both in Australia and the US, and Pro Medicus Limited (ASX: PME) is no exception.

The share price for the medical software maker has dipped more than 23% for the year so far.

Despite this, the price-to-earnings (P/E) ratio remains at an astronomical 133, according to Google Finance.

This would not stop Haselum from buying it right now.

“This medical imaging software provider is aggressively expanding overseas, particularly in the US, which accounts for about 70% of revenue.”

He especially loved the latest results, which were up significantly from the previous year.

“The company announced a first-half 2022 net profit of $20.68 million, up 52.7% on the prior corresponding period,” said Haselum.

“Given new contract wins and renewals, we believe Pro Medicus can justify its relatively high price/earnings ratio.”

The analyst community has more conviction on Pro Medicus compared to A2 Milk. Six out of eight analysts surveyed by CMC Markets currently rate the tech company as a “strong buy”.

Motley Fool contributor Tony Yoo owns A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man with a colourful shirt clasps an old fashioned phone ear piece to his ear with a look of curious puzzlement on his face as though he is pondering the anser to a question.
Broker Notes

What are brokers saying about the Telstra share price?

Brokers are feeling positive about the Telstra share price...

Read more »

man looking through window at sky scraper buildings
Broker Notes

This is the latest ASX 200 sector to be hit by downgrades

It seems there's no safe place to hide from the current volatility.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Top brokers name 3 ASX shares to buy today

Brokers are feeling bullish about these ASX shares...

Read more »

a woman stands next to a large green battery smiling and eating an apple with a lifting green arrow line in the background, indicating rising stock prices.
Resources Shares

After the sell-off, experts think these 2 lithium ASX stocks are great buys

Brokers think that these ASX lithium stocks could charge up returns.

Read more »

Broker looking at the share price.
Bank Shares

Westpac share price inches ahead despite broker cutting its price target by 16%

Westpac shares are edging higher despite a bearish broker note...

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top broker backs a tasty 20% upside for the Collins Foods share price

This ASX share could have plenty of upside ahead...

Read more »

Supermarket worker looks upset.
Broker Notes

Wesfarmers share price tumbles on broker downgrade

Wesfarmers shares are having a difficult day...

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Dividend Investing

Looking to buy ASX dividend shares? Here are 2 that experts rate highly

Telstra is one of the expert picks for solid share price growth and income returns.

Read more »